Delivery Order SPE2DB20D2104-SPE2DB23FS10T
- Not listed
- This federal contract award is for the delivery of Enbrel 50 mg/mL SureClick, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $13,863.72 firm-fixed-price delivery order was issued to the prime contractor, AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the DLA Troop Support Medical. This IDC serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range...
- This federal contract award is for the delivery of Enbrel 50 mg/mL SureClick medical supplies to the Defense Logistics Agency (DLA). The $9,582.60 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and...
- This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Enbrel 50 mg/ml SureClick medication to DLA Troop Support Medical facilities. The $7,187.22 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of October 19, 2022. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which maintains a...
- The federal contract award is for the delivery of ENBREL 50 MG/ML SURECLICKML to the Defense Logistics Agency (DLA). The $27,536.64 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award is for the delivery of ENBREL 50 MG/ML SURECLICK, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $56,647.25 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a period of performance through May 3, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is a delivery order worth $18,538.64 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The order is for the supply of ENBREL 50 MG/ML SURECLICKML, a specialty medication, with a performance period through May 2, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive range of...
- This federal contract award issued by the Defense Logistics Agency (DLA) is for the delivery of ENBREL 50 MG/ML SURECLICKML, a specialty pharmaceutical product, to the DLA Troop Support Medical. The $5,568.33 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
- The federal contract award is for the delivery of Enbrel 50 mg/mL SureClick, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $27,893.77, was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. This is a delivery order contract with a firm fixed price under the DLA's Indefinite Delivery Contract (IDC) valued up to $999,999,999.00, which runs through November 2026. The contract does not have a...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $12,559.49 firm fixed price delivery order is for the supply of the specialty pharmaceutical product Enbrel 50 mg/mL SureClick. The contract has an ultimate completion date of March 27, 2024 and does not have any set-aside designation....
- This federal contract award is for the delivery of ENBREL 50 MG/ML SURECLICKML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $57,241.15 firm fixed-price delivery order was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical division. This IDC serves as a...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FS10TDelivery Order
This federal contract award is for the delivery of Enbrel 50 mg/ml SureClick medical products by Amerisourcebergen Drug Corp to the Defense Logistics Agency (DLA). The $15,663.88 firm-fixed-price delivery order is a task under a larger $999,999,999 Indefinite Delivery Contract (IDC) held by the company's parent, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora, Inc. to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award has no set-aside designation, indicating open competition. As a major pharmaceutical distributor, Amerisourcebergen Drug Corp plays a critical role in providing essential medications and medical commodities to various federal agencies, including the Department of Defense and Department of Veterans Affairs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.7k | 2/7/23 |